Metastatic Breast Cancer Access to Care Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
This bill aims to improve access to disability benefits and Medicare coverage for individuals diagnosed with metastatic breast cancer. It eliminates the standard 5-month waiting period for Social Security Disability Insurance (SSDI) benefits and the subsequent 24-month waiting period for Medicare eligibility, which are typically required for those receiving disability benefits. This change is intended to provide quicker access to crucial support for people living with this serious form of breast cancer. The bill specifically targets these waiting periods based on a diagnosis of metastatic breast cancer.
Key provisions
- Eliminates the 5-month waiting period for SSDI benefits for individuals with metastatic breast cancer.
- Eliminates the 24-month waiting period for Medicare coverage for individuals with metastatic breast cancer.
- Modifies Section 223(a) of the Social Security Act to include ‘metastatic breast cancer’ in the list of conditions considered for SSDI benefits.
- Modifies Section 226(h) of the Social Security Act to include ‘metastatic breast cancer’ in the list of conditions considered for Medicare coverage.
Who is affected
- Individuals with metastatic breast cancer
- Social Security Disability Insurance (SSDI) recipients
- Medicare beneficiaries
Notable changes
- Reduces the time it takes for SSDI benefits to begin and for Medicare coverage to start for those with metastatic breast cancer.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
8 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours